Posts Tagged ‘anti-obesity medicines’

Incentives for Metabolic Surgery in Response to GLP-1 Medicines

January 17, 2024 — Over the past year, as the world has embraced GLP-1 medicines like semaglutide for obesity, we have heard much speculation about dire prospects for the future of metabolic surgery. Stock prices dropped earlier this year for medical device companies with big investments in bariatric surgery when Intuitive Surgical announced they were seeing a slowdown in […]

Lancet: Obesity Drugs Won’t Save Us from Cheeseburgers

January 10, 2024 — Some things never change. Half a century ago, editors of the Lancet proclaimed that “most obesity could, with care, be prevented.” Drugs have “limited usefulness” for treating obesity, they explained, and so, “we need to be more vigilant about preventing obesity throughout childhood.” After 50 years of relying on this advice, obesity prevalence has tripled. […]

LillyDirect Poised to Shake Up Access to Obesity Care

January 5, 2024 — Eli Lilly and Company has taken the unusual step of starting a direct to consumer clinical care and pharmacy program for obesity, diabetes, and migraine. If you have any doubt that LillyDirect will shake up the landscape for access to obesity care, just ask the folks at WeightWatchers. Their stock dropped by 11% yesterday when […]

The Best and Worst of 2023 in Obesity and Health

December 28, 2023 — This was a year of great progress in obesity, and with that progress came frustrations and angst. So finding the best and worst of 2023 in obesity and health is actually quite an easy and interesting task. Let’s dig right in. #1 Best: Cardiovascular Outcomes Benefit Data for Semaglutide Above all else the landmark findings […]

Angst About Holiday Food, Health, and Happiness

December 23, 2023 — The approach of the big holiday of Christmas often conjures thoughts about sharing meals and festive food. Many tables are overflowing with excess and with that excess comes a certain amount of angst about holiday food, health, and personal happiness. This year, we have a new twist on how to cope. Popular media is serving […]

The Top 10 Most Read Posts of 2023 on ConscienHealth

December 21, 2023 — No two ways about it. This has been a big year of milestones in obesity and health. We and many others are still processing what we have witnessed in these past 12 months. But one way to gain perspective is to look at 2023 stats for the posts on ConscienHealth that you, a wise group […]

Reason and Emotion in Obesity Care for Young Persons

December 18, 2023 — Both reason and emotion play a role in obesity care for young persons. Feelings about this subject are strong. The experience of living with obesity is intense for families, children, and youth. Recent reporting makes this clear. Equally clear is reporting and new data that tell us we’re not coping with it very well. Severe […]

Pills and Pokes, Different People, Different Paths

December 17, 2023 — “Are you sure you want an Ozempic pill?” In the Atlantic, Yasmin Tayag poses this question. Back in June people were bubbling with enthusiasm at the prospect of an oral small molecule – orforglipron – that might work as well as injectable semaglutide. But Tayag offers caution that we share. One size, one approach, for […]

Public Pressure Building for Access to Obesity Medicines

December 14, 2023 — New research from the University of Michigan Institute for Healthcare Policy and Innovation offers a pretty clear picture. The research team sums it up succinctly. “Medicare doesn’t cover obesity drugs, but 76% of older adults think it should.” Yes, public pressure is building for access to obesity medicines. Survey Research of Adults 50 to 80 […]

What Comes from 88 Weeks of Tirzepatide? Or Stopping It?

December 13, 2023 — “The long run is a misleading guide to current affairs. In the long run we are all dead,“ wrote John Maynard Keynes. But Keynes was obviously not a doctor. So his words don’t hold much sway over people who have questions about obesity medicines with impressive short-term results. But for those people, a new study […]